Pharmaceutical information systems and possible implementations of informed consent -- developing an heuristic

Denmark has implemented a comprehensive, nationwide pharmaceutical information system, and this system has been evaluated by the Danish Council of Ethics. The system can be seen as an exemplar of a comprehensive health information system for clinical use. The paper analyses 1) how informed consent c...

Full description

Saved in:
Bibliographic Details
Published in:BMC medical ethics 2012-11, Vol.13 (1), p.30-30, Article 30
Main Authors: Ploug, Thomas, Holm, Søren
Format: Article
Language:English
Subjects:
Autonomy
Beneficence
Clinical Trials as Topic - ethics
Clinical Trials as Topic - methods
Clinical Trials as Topic - standards
Clinical Trials as Topic - trends
Comprehension - ethics
Control
Denmark
Ethics, Research
Health information
Health information systems
Health Information Systems - ethics
Health Information Systems - organization & administration
Health Information Systems - standards
Health Information Systems - trends
Humans
Informed consent
Informed consent (Medical law)
Informed Consent - ethics
Medical informatics
Personal Autonomy
Pharmaceutical Preparations
Principle-Based Ethics
Routinisation
Social Justice
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Denmark has implemented a comprehensive, nationwide pharmaceutical information system, and this system has been evaluated by the Danish Council of Ethics. The system can be seen as an exemplar of a comprehensive health information system for clinical use. The paper analyses 1) how informed consent can be implemented in the system and how different implementations create different impacts on autonomy and control of information, and 2) arguments directed towards justifying not seeking informed consent in this context. Based on the analysis a heuristic is provided which enables a ranking and estimation of the impact on autonomy and control of information of different options for consent to entry of data into the system and use of data from the system.The danger of routinisation of consent is identified.The Danish pharmaceutical information system raises issues in relation to autonomy and control of information, issues that will also occur in relation to other similar comprehensive health information systems. Some of these issues are well understood and their impact can be judged using the heuristic which is provided. More research is, however needed in relation to routinisation of consent.
ISSN:1472-6939
1472-6939
DOI:10.1186/1472-6939-13-30